Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Health Opioids topic
No spam. Unsubscribe anytime.
Goldfinch Health outlines surgical opioid‑reduction program; no county action taken
Summary
Private firm Goldfinch Health presented a program to reduce postoperative opioid prescriptions and promote enhanced recovery after surgery; commissioners asked questions about local practice, HIPAA and applicability to county employees and possible use of opioid settlement funds, but took no action.
Goldfinch Health representatives briefed the Elko County Board of Commissioners on a surgical opioid‑reduction program that the company said aims to reduce new opioid dependence by limiting unnecessary postoperative prescribing and supporting patients after surgery.
Patrick Madigan, representing Goldfinch Health, described the company as an “upstream opioid addiction prevention” organization that promotes Enhanced Recovery After Surgery (ERAS) protocols, academic detailing to clinicians and remote nurse support for patients. Madigan said the program has been used in several states and, he said, produced a 60 percent reduction in post‑surgery opioid prescribing and a 92 percent reduction in refill rates in pilot evaluations; he cited publication of program results in a peer‑reviewed orthopedic journal.
Madigan told commissioners the company can be offered as a health benefit for public employees or deployed using opioid settlement funds. “We would ask the county to consider using our services as a health benefit for your public employees,” Madigan said, adding that Goldfinch also applies for opioid settlement dollars to underwrite countywide implementations.
Commissioners responded with a mix of interest and skepticism. Chair John Carr said some local surgical centers “are already doing a lot of this”; another commissioner noted that the statistic Madigan provided — prescriptions per 100 people — uses a CDC metric and asked whether it referred to an annual rate; Madigan said he would confirm the time frame. Commissioner Delmo and others noted progress in regulating prescribing and expressed concern about whether the program would add value now that prescribers and regulators have changed practice in recent years. Commissioner Rex expressed worry that efforts to curb prescribing could worsen treatment for chronic pain patients, and Madigan responded that the company focuses on opioid‑naive surgical patients, not chronic pain management.
No action was taken; the presentation was informational. Commissioners asked staff to review the Goldfinch proposal and said they would consider whether the county should pursue Goldfinch services for employees or fund a community program with opioid settlement dollars at a later date.
